市場調查報告書
商品編碼
1450944
2024-2032 年按刺激類型、產品、應用(帕金森氏症、癲癇、肌張力失調、強迫症等)、最終用戶和地區分類的深部腦刺激市場報告Deep Brain Stimulation Market Report by Stimulation Type, Product, Application (Parkinson's Disease, Epilepsy, Dystonia, Obsessive Compulsive Disorder, and Others), End-User, and Region 2024-2032 |
2023年,全球深部腦部刺激市場規模達到13億美元。展望未來, IMARC Group預計到2032年市場規模將達到26億美元,2024-2032年複合年成長率(CAGR)為8.3%。大眾各種運動和神經系統疾病的發生率不斷上升,微創(MI)手術方法的接受度不斷提高,以及全球醫院、療養院和診所的建設,是推動市場的一些關鍵因素。
深部腦部刺激 (DBS) 是指有助於治療各種神經和運動相關疾病的外科手術,例如帕金森氏症、癲癇、肌張力失調和強迫症 (OCD)。它涉及在大腦的某些區域植入電極以產生電脈衝來調節大腦中的異常脈衝。它依賴於一種類似起搏器的設備,稱為可編程發生器,放置在患者上胸部的皮膚下,並用一根電線將該設備連接到電極。它可以阻止神經功能障礙的形成,引起衝動,並幫助大腦有效運作。它可以幫助患者應對震顫、僵硬和運動障礙,而無需完全依賴高劑量的藥物。它用於治療抽動穢語症候群、亨廷頓舞蹈症、舞蹈病、叢集性頭痛和慢性疼痛。當藥物不再有效地維持患者良好的生活品質時,也會使用它。此外,由於 DBS 以受控方式直接改變大腦活動,因此受到世界各地神經外科醫生、神經科醫生、神經心理學家和精神病學家的推薦。
目前,由於群眾中各種運動和神經系統疾病的發生率上升,對 DBS 的需求不斷增加,這是對市場產生正面影響的主要因素之一。除此之外,越來越多的人接受微創 (MI) 手術方法來減少術後疤痕、最大限度地降低醫療費用並縮短住院時間,這提供了良好的市場前景。此外,醫院、療養院和診所的建設也在增加,以便為全球患者提供優質的醫療保健服務。隨著在改善各種神經和心理疾病的治療和診斷方面取得的不斷進步,正在推動市場的成長。除此之外,人們越來越意識到 DBS 的好處和神經系統併發症的早期發現,以及全球老年人口的不斷增加,正在支持市場的成長。此外,工作人員中各種生活方式障礙和高血壓引起的憂鬱症的發生率不斷上升,也正在加強市場的成長。此外,主要市場參與者正在將人工智慧 (AI) 和物聯網 (IoT) 融入 DBS 系統中,以創建機器人輔助植入和多目標刺激。
The global deep brain stimulation market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of the key factors driving the market.
Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson's disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington's disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.
At present, the increasing demand for DBS due to the rising occurrence of various motor and neurological disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing acceptance of minimally invasive (MI) surgical methods to reduce post-operative scarring, minimize the cost of medical bills, and decrease the duration of hospital stays is offering a favorable market outlook. Additionally, there is an increase in the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe. This, along with the rising number of advancements made in improving the treatment and diagnosis of various neurological and psychological disorders, is propelling the growth of the market. Apart from this, the increasing awareness about the benefits of DBS and early detection of neurological complications, along with the rising geriatric population worldwide, is supporting the growth of the market. In addition, the rising occurrence of various lifestyle disorders and hypertension-induced depression among working individuals is strengthening the market growth. Moreover, key market players are incorporating artificial intelligence (AI) and the internet of things (IoT) in DBS systems to create robot-assisted implantations and multitarget stimulations.
IMARC Group provides an analysis of the key trends in each segment of the global deep brain stimulation market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on stimulation type, product, application, and end-user.
Subthalamic DBS
Globus Pallidus DBS
Thalamic DBS
Pedunculopontine Nucleus DBS
The report has provided a detailed breakup and analysis of the deep brain stimulation market based on the stimulation type. This includes subthalamic DBS, globus pallidus DBS, thalamic DBS, and pedunculopontine nucleus DBS.
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
A detailed breakup and analysis of the deep brain stimulation market based on the product has also been provided in the report. This includes single channel deep brain stimulator and dual channel deep brain stimulator. According to the report, dual channel deep brain stimulator accounted for the largest market share.
Parkinson's Disease (PD)
Epilepsy
Dystonia
Obsessive Compulsive Disorder (OCD)
Others
A detailed breakup and analysis of the deep brain stimulation market based on the application has also been provided in the report. This includes Parkinson's disease (PD), epilepsy, dystonia, obsessive compulsive disorder (OCD), and others. According to the report, Parkinson's disease (PD) accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Neurological Centers
Others
A detailed breakup and analysis of the deep brain stimulation market based on the end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, neurological centers, and others. According to the report, hospitals accounted for the largest market share.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for deep brain stimulation. Some of the factors driving the North America deep brain stimulation market included the growing investment in the medical sector, rising construction of healthcare facilities, increasing occurrence of various neurological conditions among the masses, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global deep brain stimulation market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, Neuro Sigma, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.